Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by GrahamBon Dec 04, 2022 8:11am
111 Views
Post# 35149253

RE:Sales Update: Deja Vu, Again

RE:Sales Update: Deja Vu, Again
GrahamB wrote:

No posts here on the new financials...
We were told sales were coming, that this quarter it would be "big news
The facts are in:

REVENUE 9 MONTHS ENDED SEPT 30,2022= 40,060

this includes Trade accounts receivable 15,460 as I understand it

 

For the three and nine months ended September 30, 2022, basic and diluted loss per share has been calculated based on  the  loss  attributable  to  common  shareholdersof  $1,404,688 and  $3,768,472,  respectively

 

 

 

 

What happenned to the sales?
 

Last quarter and the quarter before ....and before-we were told here that huge sales were coming
 

Yet 40K over 9 months ?

with a cash burn of ~4 million a year- you need to sell 100 units a year just to break even -imo

 

We were supposed to be very "happy"in September?

Big news coming-it was said
 

Sales….

 

JUST FOR CONTEXT 

 

Total revenue for year ending Dec. 31, 2021  = ZERO

 

Total revenue for year ending Dec. 31, 2020  = $36,017

 

Total revenue for year ending Dec. 31, 2019  = $81,023

 

Total revenue for year ending Dec. 31, 2018  = $60,177

 

ALL DATA FGROM SEDAR.COM

 

So total sales over 5 years ~ 200K

 

What say you pumpers
 

Next quarter? Again

that loud flushing sound you here is the dilution from a new issue to keep the lights on
All IMO
This is for entertainiment
i know nothing-do your own DD



Pumpers playbook.
Attack the messenger.
Pump the "story" that keeps looking forward, while they fail again and again to meet stated endpoints.

Avoid discussing the facts.
The Facts are coming from the company published 

Ironic and Deceptive



All IMo
Do your own DD
My thoughts-an idiot independent investor, not a fin advisor
<< Previous
Bullboard Posts
Next >>